Corin Debuts its ApolloKnee Platform

Corin Group has globally launched its ApolloKnee surgical application and Apollo platform for robotic-assisted total knee arthroplasty.

“As the evolution of surgical robotics continues, we are excited to expand the availability of what we believe to be the next true advancement in orthopedic total joint replacement. This is a key moment for the company, and I look forward to seeing Corin continue to deliver on their Apollo innovation pipeline,” said Corin Board Chairman David Floyd, a senior advisor to private equity partner Permira.

• Plan: Surgeons can comprehensively assess each patient’s knee balance with the pre-resection BalanceBot. The planning algorithm then presents an optimized surgical plan within the specified surgeon preferences.
• Implement: The Apollo Robot, a compact, robotic cutting guide, ensures precise and efficient bone resection. Control of the ApolloKnee workflow is achieved via intraoperative gestures or a draped, touchscreen tablet.
• Learn: Automatic data collection and cloud computing integrates pre-, intra-, and post-operative information for continuous learning at every stage of the procedure.

Corin structured Apollo’s limited market release beginning in February to closely monitor early clinical use and patient outcomes as the manufacturing and supply chain established the scale for growth.

“Clinical data from the limited market release has been impressive. We can quantify the complete knee balance before and after the bony cuts are performed and early data are showing a reproducible variance in balance to the surgical plan,” Corin Global Franchise Lead Dr. Jim Pierrepont stated. “These results underscore the reliability and precision of the Apollo platform in achieving desired surgical outcomes.” 

Feedback highlights also included the reliability of using a pre-resection knee balance assessment to plan the entire knee procedure, surgical efficiency provided by the gesture-controlled workflow, and autonomous planning.

“I find ApolloKnee valuable from normal primaries to those with complex deformities. I am far less likely to recut a tibia or go back and change anything because I have the data upfront,” arthroplasty surgeon John Keggi, M.D., commented. “Now that I can visualize ligament balance, even those complex patients come out of the OR with the same result as patients with minor deformities, and in about the same period of time. It’s incredibly satisfying.”

Corin’s vision for the future includes the development of additional software applications to further enhance the Apollo platform’s capabilities. 

“Corin has had a remarkably strong start to 2024. Apollo and the ApolloKnee application now have regulatory clearance in all major markets and have successfully been used to objectively balance knees in more than 200 patients. This early success with Apollo is a testament to the dedication of our cross-functional teams, scalable manufacturing capability, and strategic initial release,” said Corin CEO Jon Serbousek, a senior advisor to private equity partner Permira.